CSIMarket
 
Syndax Pharmaceuticals Inc   (NASDAQ: SNDX)
 

Syndax Pharmaceuticals Inc's Customers Performance

SNDX



 
SNDX's Source of Revenues During the corresponding time, Syndax Pharmaceuticals Inc recorded a revenue increase by 91.76 % year on year, sequentially revenue grew by 12.22 %. While revenue at the Syndax Pharmaceuticals Inc 's corporate clients

List of SNDX Customers




for the same period Syndax Pharmaceuticals Inc recorded revenue increase by 91.76 % year on year, sequentially revenue grew by 12.22 %.

List of SNDX Customers

Syndax Pharmaceuticals Inc's Business Units
Product    142.36 % of total Revenue
Collaboration Revenue    46.75 % of total Revenue
Biopharmaceutical Cancer Therapeutics    189.11 % of total Revenue






Syndax Pharmaceuticals Inc's Comment on Sales, Marketing and Customers
















SNDX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Syndax Pharmaceuticals Inc 1,537.77 217.17 -243.25 298
SUBTOTAL 0.00 0.00 0.00 -

Sources: Syndax Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Syndax Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Syndax Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.